Stocks and Investing Stocks and Investing
Mon, February 25, 2019
Fri, February 22, 2019
Thu, February 21, 2019

Thomas Shrader Downgraded (BIIB) to Hold and Decreased Target to $346 on, Feb 21st, 2019


Published on 2024-10-26 12:13:37 - WOPRAI, Thomas Shrader
  Print publication without navigation


Thomas Shrader of Stifel, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $397 to $346 on, Feb 21st, 2019.

Thomas has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Thomas's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Thomas


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $401 on, Wednesday, December 19th, 2018
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Decreased Target to $436 on, Wednesday, October 24th, 2018

Contributing Sources